Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Schmidt

Showing results (291-300 of 448) with videos related to

Pageof 45
Sort By:
European Journal of Medicinal Chemistry|July 10, 2012
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assayAlexander Rohe, Christiane Göllner, Kanin Wichapong, et al.
Bioorganic Chemistry|October 18, 2024
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degradersHany S Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Acta Oto-Laryngologica|May 16, 2006
Diagnostic work-up and outcome of cervical metastases from an unknown primaryOrlando Guntinas-Lichius, J Peter Klussmann, Stephen Dinh, et al.
Plos One|May 10, 2016
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem CellsMegan G Massa, Barbara Gisevius, Sarah Hirschberg, et al.
Molecules (Basel, Switzerland)|March 28, 2026
Insights into the Design of MYC-Targeting Proteolysis Targeting Chimeras (PROTACs)Abdallah M Alfayomy, Sven Hagemann, Matthias Schmidt, et al.
Nuklearmedizin. Nuclear Medicine|December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancerCharlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Frontiers in Immunology|February 15, 2021
Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic ImmunitySabrina Rueschenbaum, Chengcong Cai, Matthias Schmidt, et al.
Endocrine|May 19, 2020
Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experienceCostanza Chiapponi, Nadine Lürssen, Birgit Cremer, et al.
Environmental Microbiology|June 30, 2021
Iron corrosion by methanogenic archaea characterized by stable isotope effects and crust mineralogyMarc Tamisier, Matthias Schmidt, Carsten Vogt, et al.
Nature Communications|February 9, 2021
Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosisLynn Radamaker, Julian Baur, Stefanie Huhn, et al.
Pageof 45

Showing results (291-300 of 448) with videos related to

Sort By:
Pageof 45
European Journal of Medicinal Chemistry|July 10, 2012
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assayAlexander Rohe, Christiane Göllner, Kanin Wichapong, et al.
Bioorganic Chemistry|October 18, 2024
Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degradersHany S Ibrahim, Menglu Guo, Sebatian Hilscher, et al.
Acta Oto-Laryngologica|May 16, 2006
Diagnostic work-up and outcome of cervical metastases from an unknown primaryOrlando Guntinas-Lichius, J Peter Klussmann, Stephen Dinh, et al.
Plos One|May 10, 2016
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem CellsMegan G Massa, Barbara Gisevius, Sarah Hirschberg, et al.
Molecules (Basel, Switzerland)|March 28, 2026
Insights into the Design of MYC-Targeting Proteolysis Targeting Chimeras (PROTACs)Abdallah M Alfayomy, Sven Hagemann, Matthias Schmidt, et al.
Nuklearmedizin. Nuclear Medicine|December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancerCharlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Frontiers in Immunology|February 15, 2021
Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic ImmunitySabrina Rueschenbaum, Chengcong Cai, Matthias Schmidt, et al.
Endocrine|May 19, 2020
Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experienceCostanza Chiapponi, Nadine Lürssen, Birgit Cremer, et al.
Environmental Microbiology|June 30, 2021
Iron corrosion by methanogenic archaea characterized by stable isotope effects and crust mineralogyMarc Tamisier, Matthias Schmidt, Carsten Vogt, et al.
Nature Communications|February 9, 2021
Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosisLynn Radamaker, Julian Baur, Stefanie Huhn, et al.
Pageof 45